We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical finasteride (5-alpha-reductase inhibitor solution)
The same drug as oral finasteride, applied to the scalp — with a systemic-sparing claim that the pharmacokinetic data only partly supports.
Prescription medication — not a dietary supplement
Finasteride (topical) is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Most Finasteride (topical) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2009–2025 with a typical study size of 77 participants.
Based on 8 studies · 1 meta-analysis · 5 RCTs · 794 total participants
Confidence
Moderate confidenceBy outcome
A 458-patient phase III with a double-dummy oral comparator is strong evidence for the hair endpoint, and two independent lines show topical matching oral on hair count. Held at 6.5 because the literature is small (the systematic review found seven articles), the supporting trials are single-centre and short, and the systemic-sparing rationale — the main reason to choose topical over oral — is only partly supported by the pharmacokinetic data.
Topical finasteride was developed to give oral finasteride’s hair effect while keeping the drug at the follicle. The phase III trial delivers on efficacy: target area hair count rose 20.2 against 6.7 hairs on placebo, numerically similar to oral. The exposure claim is the part to read carefully.
In the dedicated pharmacokinetic study, serum DHT fell 60-70% at the doses studied — and the systematic review found plasma DHT significantly reduced too.
Lower doses spared serum DHT more (24-26% at 100-200 µL) while still cutting scalp DHT roughly in half, so the trade is real but DOSE-DEPENDENT rather than automatic. Anyone choosing topical specifically to avoid systemic 5-alpha-reductase inhibition should know that.
Finasteride inhibits type II 5-alpha-reductase, cutting conversion of testosterone to dihydrotestosterone, the androgen that miniaturises follicles in androgenetic alopecia. Applied to the scalp, it reduced scalp DHT by roughly 70% at once-daily dosing.
The point of the topical route is to keep the drug local. In practice serum DHT still fell 60-70% at the studied doses, and only the lower doses (100-200 µL) held serum reduction to 24-26% while still halving scalp DHT.
Do not use or handle. Finasteride is teratogenic to a male fetus, and the topical route does not eliminate systemic absorption.
Discuss with a clinician. Serum DHT falls substantially even with topical use.
Using topical finasteride alongside an oral 5-alpha-reductase inhibitor stacks the same mechanism. Serum DHT already falls 60-70% with the topical alone at studied doses, so the combination offers no clear extra benefit and compounds systemic suppression.
Finasteride (topical) has an evidence score of 6.5/10 — moderate evidence based on 8 indexed studies, including 1 meta-analysis. The same drug as oral finasteride, applied to the scalp — with a systemic-sparing claim that the pharmacokinetic data only partly supports. Representative study: PMID 41051009.
The commonly studied dose of Finasteride (topical) is Apply finasteride 0.25% topical solution to the scalp once daily. Lower applied volumes reduce serum DHT less while still cutting scalp DHT substantially.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Finasteride (topical) is in the evening. It can be taken on an empty stomach. Once-daily dosing gave the largest scalp DHT reduction (about 70%) in the pharmacokinetic study; evening application lets it sit undisturbed.
Finasteride (topical) should be used with caution — talk to a healthcare provider before taking it. The most commonly reported side effects are local scalp irritation or itching, reduced libido or erectile difficulty (reported with systemic 5-ARI exposure). Use caution if any of these apply to you: Pregnancy — finasteride is teratogenic and can cause genital abnormalities in a male fetus; Women who are or may become pregnant should not handle the solution; Known hypersensitivity to finasteride.
Finasteride
Mostly mechanism / observationalA prescription 5α-reductase type-II inhibitor that lowers DHT to treat male pattern hair loss (1 mg, Propecia) and benign prostatic hyperplasia (5 mg, Proscar). The hair and prostate benefits are well-proven in large RCTs. The honest caveats are real and prominent: sexual side effects (erectile dysfunction, decreased libido) in a minority of men, a disputed but important 'post-finasteride syndrome' with persistent symptoms, and a depression/suicidality safety signal in pharmacovigilance data. It is NOT a longevity drug.
Minoxidil (oral & topical)
Mostly mechanism / observationalA potassium-channel-opening vasodilator — originally an oral antihypertensive — whose well-documented hypertrichosis side effect made it the first FDA-approved hair-loss drug. Topical 2–5% (Rogaine) is OTC and proven in androgenetic alopecia; low-dose ORAL minoxidil (LDOM, ~0.25–5 mg) is an off-label, rapidly adopted alternative with real but generally mild cardiovascular/hypertrichosis side effects. A drug, not a supplement — and not a longevity compound.
Dutasteride
Mostly mechanism / observationalA dual 5α-reductase (type I + II) inhibitor approved for benign prostatic hyperplasia and used off-label for male pattern hair loss. It suppresses DHT more deeply than finasteride (which blocks only type II), and head-to-head it beats finasteride for hair regrowth. It carries the same sexual and mood side-effect concerns as finasteride — with a much longer half-life, so any persistent effects clear more slowly. A prescription drug, not a supplement, and not a longevity drug.
Adapalene
Mostly mechanism / observationalA modern topical retinoid for acne — now available over the counter (0.1%) as well as by prescription (0.3%). A drug, not a supplement or cosmetic. Adapalene is a third-generation retinoid selective for the retinoic-acid receptor beta; it normalizes how skin cells shed (comedolytic) and is anti-inflammatory. The honest framing: this is one of the best-evidenced acne treatments — a 5-trial meta-analysis and a 40-trial network meta-analysis show it matches tretinoin's efficacy with faster onset and notably better tolerability, and the adapalene-benzoyl peroxide combination is among the most effective regimens available. Caveats: it still causes retinoid irritation and slow onset, it is not superior to (only as good as) other retinoids, and — as a retinoid — it is generally avoided in pregnancy.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed September 2026 · evidence from 8 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.